Mortality associated with atrial fibrillation in patients with myocardial infarction: A systematic review and meta-analysis

Circulation

Volumn 123, Issue 15, 2011, Pages 1587-1593

  Jabre, Patricia ^a,d,e   Roger, Véronique L ^a   Murad, Mohammad H ^b   Chamberlain, Alanna M ^a   Prokop, Larry ^a   Adnet, Frédéric ^c   Jouven, Xavier ^e  

^a MAYO CLINIC   (United States)

^b Knowledge and Encounter Research Unit   (United States)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e INSERM   (France)

Author keywords

atrial fibrillation; mortality; myocardial infarction

Indexed keywords

CARDIAC PATIENT; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; MEDICAL HISTORY; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ADULT; ATRIAL FIBRILLATION; META ANALYSIS; MYOCARDIAL INFARCTION; RISK FACTOR;

ADULT; ATRIAL FIBRILLATION; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 79955524006     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.986661     Document Type: Review

References (59)

1. Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction: SPRINT Study Group. Eur Heart J. 1992;13:45-50.
2. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience: Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30:406-413. (Pubitemid 27339320)
3. Eldar M, Canetti M, Rotstein Z, Boyko V, Gottlieb S, Kaplinsky E, Behar S. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era: SPRINT and Thrombolytic Survey Groups. Circulation. 1998;97:965-970. (Pubitemid 28125468)
4. Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, Mizuno H, Fukunami M, Koretsune Y, Takeda H, Hori M. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92: 1150-1154. (Pubitemid 37377822)
5. Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, Santoro L, Tognoni G. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart. 2001;86: 527-532. (Pubitemid 32999863)
6. Rathore SS, Berger AK, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ, Solomon AJ. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000;101:969-974. (Pubitemid 30131697)
7. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J. 2000;140:878-885.
8. Berton G, Cordiano R, Cucchini F, Cavuto F, Pellegrinet M, Palatini P. Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up. Int J Clin Pract. 2009;63:712-721.
9. Lehto M, Snapinn S, Dickstein K, Swedberg K, Nieminen MS. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J. 2005;26:350-356. (Pubitemid 40287380)
10. Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson FA Jr, Fox KA, Gore JM, Goldberg RJ, Eagle KA. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol. 2003;92:1031-1036. (Pubitemid 37329526)
11. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction: TRACE Study Group: TRAndolapril Cardiac Evaluation. Eur Heart J. 1999;20:748-754. (Pubitemid 29209908)
12. Saczynski JS, McManus D, Zhou Z, Spencer F, Yarzebski J, Lessard D, Gore JM, Goldberg RJ. Trends in atrial fibrillation complicating acute myocardial infarction. Am J Cardiol. 2009;104:169-174.
13. Asanin M, Perunicic J, Mrdovic I, Matic M, Vujisic-Tesic B, Arandjelovic A, Vasiljevic Z, Ostojic M. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction. Eur J Heart Fail. 2005;7:671-676. (Pubitemid 40733002)
14. Li K, Huo Y, Ding YS. Clinical profile and outcomes of atrial fibrillation in elderly patients with acute myocardial infarction. Chin Med J. 2008; 121:2388-2391.
15. Trappolini M, Scorza A, Chillotti FM, Trappolini F, Danese A, De Vito F, Luberti E, Angrisani L, Braucci S. Prognostic significance of atrial fibrillation in thrombolysed and non thrombolysed patients. Minerva Cardioangiol. 2006;54:471-479. (Pubitemid 44689843)
16. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30:1038-1045.
17. Kober L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R, Maggioni AP, Mareev V, Opolski G, Van de Werf F, Zannad F, Ertl G, Solomon SD, Zelenkofske S, Rouleau JL, Leimberger JD, Califf RM. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail. 2006;8:591-598. (Pubitemid 44604352)
18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
19. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012. (Pubitemid 30214957)
20. Lau DH, Huynh LT, Chew DP, Astley CM, Soman A, Sanders P. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol. 2009;104:1317-1323.
21. Klass M, Haywood LJ. Atrial fibrillation associated with acute myocardial infarction: a study of 34 cases. Am Heart J. 1970;79:752-760.
22. Cristal N, Peterburg I, Szwarcberg J. Atrial fibrillation developing in the acute phase of myocardial infarction: prognostic implications. Chest. 1976;70:8-11.
23. Liem KL, Lie KI, Durrer D, Wellens HJ. Clinical setting and prognostic significance of atrial fibrillation complicating acute myocardial infarction. Eur J Cardiol. 1976;4:59-62.
24. Liberthson RR, Salisbury KW, Hutter AM Jr, DeSanctis RW. Atrial tachyarrhythmias in acute myocardial infarction. Am J Med. 1976;60: 956-960.
25. Kobayashi Y, Katoh T, Takano T, Hayakawa H. Paroxysmal atrial fibrillation and flutter associated with acute myocardial infarction: hemody- namic evaluation in relation to the development of arrhythmias and prognosis. Jpn Circ J. 1992;56:1-11.
26. Cicek D, Camsari A, Pekdemir H, Kiykim A, Akkus N, Sezer K, Diker E. Predictive value of P-wave signal-averaged electrocardiogram for atrial fibrillation in acute myocardial infarction. Ann Noninvasive Electrocardiol. 2003;8:233-237. (Pubitemid 38569982)
27. Siu CW, Jim MH, Ho HH, Miu R, Lee SW, Lau CP, Tse HF. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest. 2007;132:44-49. (Pubitemid 47071765)
28. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/ oxford.htm. Accessed January 1, 2008.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560. (Pubitemid 37088507)
30. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
31. Lopes RD, Elliott LE, White HD, Hochman JS, Van de Werf F, Ardissino D, Nielsen TT, Weaver WD, Widimsky P, Armstrong PW, Granger CB. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30:2019-2028.
32. Tangelder MJ, Frison L, Weaver D, Wilcox RG, Bylock A, Emanuelsson H, Held P, Oldgren J. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the Efficacy and Safety of the Oral Direct Thrombin Inhibitor Ximelagatran in Patients With Recent Myocardial Damage (ESTEEM) trial. Am Heart J. 2008;155:382-387.
33. Bigger JT Jr, Fleiss JL, Rolnitzky LM, Merab JP, Ferrick KJ. Effect of digitalis treatment on survival after acute myocardial infarction. Am J Cardiol. 1985;55:623-630. (Pubitemid 15148230)
34. Goldberg RJ, Seeley D, Becker RC, Brady P, Chen ZY, Osganian V, Gore JM, Alpert JS, Dalen JE. Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. Am Heart J. 1990;119: 996-1001. (Pubitemid 20155273)
35. Hunt D, Sloman G, Penington C. Effects of atrial fibrillation on prognosis of acute myocardial infarction. Br Heart J. 1978;40:303-307. (Pubitemid 8313609)
36. Koracevic GP, Petrovic S, Damjanovic M, Stanojlovic T. Association of stress hyperglycemia and atrial fibrillation in myocardial infarction. Wien Klin Wochenschr. 2008;120:409-413.
37. Madias JE, Patel DC, Singh D. Atrial fibrillation in acute myocardial infarction: a prospective study based on data from a consecutive series of patients admitted to the coronary care unit. Clin Cardiol. 1996;19: 180-186. (Pubitemid 26314328)
38. Mahon NG, Codd MB, McKenna CJ, O'Rorke C, McCann HA, Sugrue DD. Characteristics and outcomes in patients with acute myocardial infarction with ST-segment depression on initial electrocardiogram. Am Heart J. 2000;139:311-319. (Pubitemid 30090809)
39. Petretta M, Canonico V, Bianchi V, Attisano T, Arrichiello P, Morgano G, Capozzi E, Bonaduce D. Influence of age on the short- and medium-term prognosis in patients with acute myocardial infarct [in Italian]. G Ital Cardiol. 1991;21:395-408.
40. Rastenyte D, Jancaityte L. Sex differences in one-year mortality after a first-ever myocardial infarction. Medicina (Kaunas). 2005;41:754-759.
41. Sakata K, Kurihara H, Iwamori K, Maki A, Yoshino H, Yanagisawa A, Ishikawa K. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol. 1997;80:1522-1527. (Pubitemid 28011823)
42. Sankaranarayanan R, James MA, Nuta B, Townsend M, Kesavan S, Burtchaell S, Holloway R, Ewings P. Does atrial fibrillation beget ventricular fibrillation in patients with acute myocardial infarction? Pacing Clin Electrophysiol. 2008;31:1612-1619.
43. Suarez G, Herrera M, Vera A, Torrado E, Ferriz J, Arboleda JA. Prediction on admission of in-hospital mortality in patients older than 70 years with acute myocardial infarction. Chest. 1995;108:83-88.
44. Sugiura T, Iwasaka T, Takahashi N, Nakamura S, Taniguchi H, Nagahama Y, Matsutani M, Inada M. Atrial fibrillation in inferior wall Q-wave acute myocardial infarction. Am J Cardiol. 1991;67:1135-1136.
45. Torres M, Rocha S, Marques J, Nabais S, Rebelo A, Pereira MA, Azevedo P, Correia A. Impact of atrial fibrillation in acute coronary syndromes. Rev Port Cardiol. 2008;27:1407-1418.
46. Cui K, Gu S, Ding YS, Zhang Y, Li Y, Zheng H. Effects of atrial fibrillation/atrial flutter on the short and medium-term prognosis of patients with acute myocardial infarction. J Interv Radiol. 2008;17: 594-596.
47. Galcera TJ, Melgarejo MA, Garcia AA, Baranco PM, Martinez-Lozano AF, Rodriguez FS. Incidence, clinical characteristics and prognostic significance of supraventricular tachyarrhythmias in acute myocardial infarction [in Spanish]. Rev Esp Cardiol. 1999;52:647-655.
48. Janion M, Kurzawski J. Myocardial infarction in women complicated by atrial fibrillation. Polski Przeglad Kardiologiczny. 2001;3:41-45. (Pubitemid 34919290)
49. Nielsen FE, Sorensen HT, Christensen JH, Ravn L, Rasmussen SE. Reduced occurrence of atrial fibrillation in acute myocardial infarction treated with streptokinase. Eur Heart J. 1991;12:1081-1083.
50. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039-1045. (Pubitemid 27435898)
51. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation. 2004;109:2839-2843. (Pubitemid 38780296)
52. Ehrlich JR, Nattel S, Hohnloser SH. Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol. 2002; 13:399-405. (Pubitemid 34407608)
53. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003; 107:2920-2925. (Pubitemid 36736633)
54. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420. (Pubitemid 35340537)
55. Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J. 2004;147:463-467. (Pubitemid 38880866)
56. Ait Mokhtar O, Bonello L, Armero S, Sbragia P, Paganelli F. Early and late outcomes of clopidogrel and Coumadin combination for patients on oral anticoagulants undergoing coronary stenting. Cardiovasc Revasc Med. 2010;11:159-162.
57. Stenestrand U, Lindback J, Wallentin L. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Circulation. 2005;112:3225-3231. (Pubitemid 43739366)
58. Coory MD. Comment on: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;39:932.
59. Higgins JP. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158-1160.